logo

For the Inventor, By the Inventor

Latham, NY, United States of America

Kande K D Amarasinghe

This inventor holds 16 USPTO granted patents, primarily in Protein Tyrosine Phosphatases. Top assignees: Aerpio Therapeutics, Inc., The Procter Gamble Company, Warner Chilcott Company, LLC. Active years: 2009-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kande K D Amarasinghe. Retrieved from https://idiyas.com/inventor/kande-k-d-amarasinghe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 15

Forward Citations = 576(Granted Patents)


Location History:

  • Latham, NY (US) (2009 - 2012)
  • Ellicott City, MD (US) (2014 - 2019)

Company Filing History:

goldMedal11 out of 35 
 
Aerpio Therapeutics, Inc.
 patents
silverMedal2 out of 17,692 
 
The Procter Gamble Company
 patents
bronzeMedal2 out of 39 
 
Warner Chilcott Company, LLC
 patents
4. 1 out of 8 
 
Aerpio Pharmaceuticals, Inc.
 patents

Years Active: 2009-2019

Loading Chart...
Areas of Expertise:
Protein Tyrosine Phosphatase
Inhibitors
Therapeutic Applications
Biochemical Research
Drug Development
Cancer Treatment
Signal Transduction
Enzyme Regulation
Pharmacology
Molecular Biology
Latham, NY
16 patents (USPTO):Explore Patents
1. 10463650 - Human protein tyrosine phosphatase inhibitors and methods of use (2019-11-05),
2. RE46592 - Human protein tyrosine phosphatase inhibitors and methods of use (2017-10-30),
3. 9795594 - Human protein tyrosine phosphatase inhibitors and methods of use (2017-10-24),
4. 9284285 - Human protein tyrosine phosphatase inhibitors and methods of use (2016-03-15),
5. 9126958 - Human protein tyrosine phosphatase inhibitors and methods of use (2015-09-08),
6. 8946232 - Human protein tyrosine phosphatase inhibitors and methods of use (2015-02-03),
7. 8895563 - Human protein tyrosine phosphatase inhibitors and methods of use (2014-11-25),
8. 8846685 - Human protein tyrosine phosphatase inhibitors and methods of use (2014-09-30),
9. 8338615 - Human protein tyrosine phosphatase inhibitors and methods of use (2012-12-25),
10. 8329916 - Human protein tyrosine phosphatase inhibitors and method of use (2012-12-11),
11. 8258311 - Human protein tyrosine phosphatase inhibitors and methods of use (2012-09-04),
12. 8188125 - Human protein tyrosine phosphatase inhibitors and methods of use (2012-05-29),
13. 8106078 - Human protein tyrosine phosphatase inhibitors and methods of use (2012-01-31),
14. 7795444 - Human protein tyrosine phosphatase inhibitors and methods of use (2010-09-14),
15. 7622593 - Human protein tyrosine phosphatase inhibitors and methods of use (2009-11-24),

Title: Kande K D Amarasinghe: Innovator in Protein Tyrosine Phosphatase Inhibitors

Introduction

Kande K D Amarasinghe is a notable inventor based in Latham, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of human protein tyrosine phosphatase inhibitors. With a total of 16 patents to his name, Amarasinghe's work has the potential to impact various therapeutic applications.

Latest Patents

Amarasinghe's latest patents focus on human protein tyrosine phosphatase beta (HPTP-β) inhibitors. These compounds are designed to regulate angiogenesis, which is crucial for various biological processes. The patents detail compositions that include these inhibitors and methods for their use in regulating angiogenesis.

Career Highlights

Throughout his career, Amarasinghe has worked with prominent companies such as Aerpio Therapeutics, Inc. and The Procter & Gamble Company. His experience in these organizations has allowed him to refine his expertise in the development of innovative therapeutic solutions.

Collaborations

Amarasinghe has collaborated with notable professionals in his field, including Jeffrey Lyle Gray and Cynthia Monesa Clark. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kande K D Amarasinghe is a distinguished inventor whose work in protein tyrosine phosphatase inhibitors showcases his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…